These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3802715)

  • 1. delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects.
    Gorchein A; Webber R
    Clin Sci (Lond); 1987 Jan; 72(1):103-12. PubMed ID: 3802715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of 5-aminolaevulinic acid by reversed phase HPLC and fluorescence detection.
    Minder EI
    Clin Chim Acta; 1986 Nov; 161(1):11-8. PubMed ID: 3815852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms.
    Mustajoki P; Timonen K; Gorchein A; Seppäläinen AM; Matikainen E; Tenhunen R
    Eur J Clin Invest; 1992 Jun; 22(6):407-11. PubMed ID: 1633836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of delta-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection.
    Gorchein A
    Biochem J; 1984 May; 219(3):883-9. PubMed ID: 6547602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-aminolaevulinic acid metabolism in normal and lead-exposed humans.
    Meredith PA; Moore MR; Campbell BC; Thompson GG; Goldberg A
    Toxicology; 1978 Feb; 9(1-2):1-9. PubMed ID: 653730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria.
    Percy VA; Shanley BC
    S Afr Med J; 1977 Jul; 52(6):219-22. PubMed ID: 897913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticonvulsant drugs on serum delta-aminolaevulinic acid levels in non-porphyric subjects.
    Gorchein A; Webber R; Burnett D; Goudie JH
    Br J Clin Pharmacol; 1987 Dec; 24(6):847-8. PubMed ID: 3440108
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients.
    Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A
    J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal reabsorption and secretion of delta-aminolevulinic acid in the rat.
    O'Flaherty EJ; Hammond PB; Taylor E
    Fundam Appl Toxicol; 1981; 1(3):278-81. PubMed ID: 7184792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radical generation during delta-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinpathies.
    Monteiro HP; Abdalla DS; Augusto O; Bechara EJ
    Arch Biochem Biophys; 1989 May; 271(1):206-16. PubMed ID: 2540713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta-Aminolaevulinic acid uptake, toxicity, and effect on [14C]gamma-aminobutyric acid uptake into neurons and glia in culture.
    Percy VA; Lamm MC; Taljaard JJ
    J Neurochem; 1981 Jan; 36(1):69-76. PubMed ID: 7463061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of plasma delta-aminolaevulinic acid levels. Applications.
    Goujon R; Philibert E; Bernard P; Normand J; Boucherat M
    Ann Biol Clin (Paris); 1992; 50(10-11):675-7. PubMed ID: 1306950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematin therapy and leucocyte delta-aminolevulinic-acid-synthase activity in prolonged attack of acute porphyria.
    McColl KE; Thompson GT; Moore MR; Goldberg A
    Lancet; 1979 Jan; 1(8108):133-4. PubMed ID: 84154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria.
    Müller WE; Snyder SH
    Ann Neurol; 1977 Oct; 2(4):340-2. PubMed ID: 214024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte delta-aminolaevulinic acid dehydratase activity and changes in delta-aminolaevulinic acid concentration in various forms of anaemia.
    Campbell BC; Meredith PA; Moore MR; Goldberg A
    Br J Haematol; 1978 Nov; 40(3):397-400. PubMed ID: 749926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some parameters of haem synthesis in dialysed and non-dialysed uraemic patients.
    Yalouris AG; Lyberatos C; Chalevelakis G; Theodosiadou E; Billis A; Raptis S
    Scand J Haematol; 1986 Nov; 37(5):404-10. PubMed ID: 2856853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacology of delta-aminolaevulinic acid. II. Effect of chronic administration in mice.
    Edwards S; Jackson D; Reynoldson J; Shanley B
    Neurosci Lett; 1984 Sep; 50(1-3):169-73. PubMed ID: 6493622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorbent therapy of the porphyrias. III. Comparative efficacy of experimental plasma perfusion with several commercial hemoperfusion cartridges.
    Tishler PV; Winston SH
    Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):389-93. PubMed ID: 6503474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute porphyric attack. I. The electrolyte disorder of the acute porphyric attack and the possible role of delta-aminolaevulic acid.
    Eales L; Dowdle EB; Sweeney GD
    S Afr Med J; 1971 Sep; ():89-97. PubMed ID: 5150300
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes.
    Sardh E; Andersson DE; Henrichson A; Harper P
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):66-71. PubMed ID: 19268004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.